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Introduction
Melanomas are tumors arising from melanocytes, which
are neuroectodermal-derived cells located in the basal
layers of the skin or some mucosal membranes. They
usually occur in sunlight-exposed cutaneous areas like
the face, neck, and extremities. Melanomas arising from
the nasal cavity are extremely rare. Sinonasal melanomas
account for less than 1% of all melanomas. The symp-
toms of malignant mucosal melanoma are nonspecific
and they appear according to tumor location; thus,
diagnosis is often delayed. The most common clinical
presentations of nasal cavity melanomas are epistaxis
and nasal obstruction. We report the case of a 78-
year-old man who had symptoms of epistaxis. Tumor
mass was noted over the left nasal cavity, and biopsy
revealed malignant mucosal melanoma.
Case Report
A 78-year-old man suffered from occasional episodes of
left side epistaxis and blood-tinged sputum for about
1 month. He visited a local hospital, and a tumor mass
was found in his left nasal cavity. Biopsy revealed malig-
nant melanoma and he was then referred to our insti-
tute. A dark-colored tumor mass over the left-side
nasal floor with easy touch bleeding was found on
nasal endoscopy (Figure 1). Head and neck magnetic
resonance imaging disclosed a localized tumor mass
over the nasal cavity without definite bony destruc-
tion or neck metastasis. There was no paranasal sinus,
or nasopharyngeal, orbital and intracranial extension
(Figure 2). Tumor survey series showed no regional or
distant metastasis or any suspicious cutaneous lesions.
Therefore, we arranged wide excision of the tumor
via endoscopic surgery. During the operation, several
small pigmentations were noted over the nasophar-
ynx, bilateral torus tubarius, and bilateral nasal floors.
Resection of these pigmentations was also performed.
Tumor pathology revealed malignant mucosal mela-
noma with epithelioid growth pattern. No vascular or
lymphatic invasion was found microscopically. Surgical
margins could not be clearly defined because they
were only fragmented specimens through endoscopic
approach. The pigmented areas mentioned above
showed only melanin pigment depositions without
malignant tumor cells (Figure 3). The final diagnosis
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Malignant mucosal melanoma in nasal cavity
was nasal cavity malignant mucosal melanoma, and
the clinical stage was T3N0M0, stage III, according
to the American Joint Committee on Cancer 2010
cancer staging system. The patient received adjuvant
radiation about 2 weeks later.
Discussion
Malignant melanoma is a common malignant skin
tumor. However, primary malignant mucosal melanoma
is a rare entity. Mucosal melanomas are neoplasms with
a more aggressive behavior than cutaneous lesions.
The reported incidence of mucosal melanomas is only
about 0.5–3.0% of all malignant melanomas of all sites
in the upper aerodigestive tract. Sinonasal mucosal
Figure 1. Nasal endoscopy shows a dark-colored tumor mass
(white arrow) over the left nasal floor. Black arrow = nasal septum.
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Figure 2. Magnetic resonance imaging: (A) coronal view; (B) axial view. A hypointense tumor mass (arrows) on the left nasal floor seen
on T2-weighted imaging; no paranasal sinus or nasopharyngeal, orbital and intracranial extension are noted.
BA
Figure 3. (A) Tumor cells of malignant mucosal melanoma with epithelioid growth pattern (Fontana-Masson stain, 200×). (B) Only
melanin pigment depositions (arrows) without malignant tumor cells were found in the other pigmented areas (Fontana-Masson stain,
100×).
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melanomas, although they are the most frequent of
head and neck melanomas, account for less than 1% of
all melanomas and less than 5% of all sinonasal tract
neoplasms.1 The etiology and pathogenesis of mucosal
melanoma is still poorly understood. It is believed that
mucosal melanoma arises from melanocytes that migrate
from neural crest to sinonasal mucosa.
Sinonasal mucosal melanomas are usually diagnosed
in the elderly, with the peak incidence being in the 7th
decade of life. They are found equally in both sexes,
although some reports showed a slight male predom-
inance. In the nasal cavity, the most common sites are
the nasal septum (41%), middle turbinate (29%), infe-
rior turbinate (23%), lateral nasal wall (7%), and nasal
floor (1%).2 Most nasal melanomas appear as pig-
mented, polypoid, fleshy and friable masses, and thus
might be initially diagnosed as benign lesions.3 The
symptoms vary according to the tumor extent and
location. Epistaxis is the most common presentation,
followed by nasal obstruction, facial pressure, mass le-
sion, pain, and rhinorrhea. Diagnosis is usually delayed
due to the nonspecific symptoms.
Diagnosis of mucosal melanomas is mainly based
on histologic findings and immunostain because their
microscopic features could be easily misdiagnosed as
lymphoma, rhabdomyosarcoma, plasmacytoma, olfac-
tory neuroblastoma, and poorly differentiated carci-
noma. They are positive for S100 protein, vimentin,
and specific melanocytic markers such as Melan-A and
HMB45 antigens.4 In the tumor, abundance of melanin
can be detected by magnetic resonance imaging, with
the characteristics of hyperintensity on T1-weighted
imaging and hypointensity on T2-weighted imaging.5
However, sometimes, the melanin in malignant mucosal
melanoma is scanty or absent.
Mucosal melanomas usually have early vasolymphatic
invasion, multiple and satellite formation, which result
in easy local recurrence.6 If there is local failure, espe-
cially when it is repeated, an increased risk of distant
metastasis and poor prognosis can be expected. Other
poor prognostic factors include advanced age, obstruc-
tive symptoms, tumor size >3cm, vascular invasion into
skeletal muscle and bone, high mitotic count, marked
cellular pleomorphism and distant metastasis.1
Up to now, wide excision is the treatment of choice
when the tumor is localized. However, adjuvant ther-
apy like radiotherapy or chemotherapy is often needed.
Some authors have suggested that radical surgery
should be performed at the presentation of localized
melanomas. Achievement of local tumor control pro-
vides the possibility of an increase in survival rate,
although the average 5-year survival rate is only about
15–20%, and is considered to be unsatisfactory. Thus,
many clinicians have tried to find effective adjuvant
treatments to improve the long-term outcome. Radio-
therapy is the most common adjuvant therapy post-
operatively, and early intervention was reported to lead
to better local control and longer disease-free survival.7
Chemotherapy drugs such as dacarbazine, cisplatin,
ranimustine and tamoxifen are usually reserved for sys-
temic disease or palliation. However, the actual role of
postoperative radiotherapy or chemotherapy in head
and neck mucosal melanomas has not yet been clearly
defined, and the results have varied among different
studies. Further studies are therefore needed. Immuno-
therapy, like interferon and Bacillus Calmette-Guérin
vaccine, has been used in some cases and may play a
role in the future.
In our patient, we performed wide tumor excision
via nasal endoscopy due to the localized tumor extent.
Many melanin depositions were found incidentally dur-
ing the operation, although no tumor cells in these
lesions were noted in the final pathology report. As
mucosal melanomas have a multicentric characteristic,
possible malignant changes in the pigmented areas
could not be completely excluded. Thus, postopera-
tive adjuvant radiotherapy is needed and long-term
follow-up must be done.
References
1. Bothale KA, Maimoon SA, Patrikar AD, Mahore SD. Mucosal
malignant melanoma of the nasal cavity. Indian J Cancer 2009;
46:67–70.
2. Díaz Molina JP, Rodrigo Tapia JP, Llorente Pendas JL, Suárez
Nieto C. Sinonasal mucosal melanomas: review of 17 cases.
Acta Otorrinolaringol Esp 2008;59:489–93.
3. Cheng YF, Lai CC, Ho CY, Shu CH, Lin CZ. Toward a better
understanding of sinonasal mucosal melanoma: clinical review
of 23 cases. J Chin Med Assoc 2007;70:24–9.
4. Hofbauer GF, Böni R, Simmen D, Mihic D, Nestle FO, Burg G,
Dummer R. Histological, immunological and molecular fea-
tures of a nasal mucosa primary melanoma associated with
nasal melanosis. Melanoma Res 2002;12:77–82.
5. Yang BT, Wang ZC, Xian JF, Chen QH. MR imaging features
of primary mucosal melanoma of the eustachian tube: report of
2 cases. AJNR Am J Neuroradiol 2009;30:431–3.
6. Mendenhall WM, Amdur RJ, Hinerman RW, Werning JW,
Villaret DB, Mendenhall NP. Head and neck mucosal melanoma.
Am J Clin Oncol 2005;28:626–30.
7. Nakashima JP, Viégas CM, Fassizoli AL, Rodrigues M, Chamon
LA, Silva JH, Dias FL, et al. Postoperative adjuvant radiation
therapy in the treatment of primary head and neck mucosal
melanomas. ORL J Otorhinolaryngol Relat Spec 2008;70:
344–51.
